Nitric oxide supplement ( DrugBank: Nitric Oxide )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
251	Urea cycle disorder	2

251. Urea cycle disorder

---

Clinical trials : 54 /  Drugs : 61 - (DrugBank : 15) / Drug target genes : 3 - Drug target pathways : 28

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03064048 (ClinicalTrials.gov)	September 15, 2017	10/2/2017	Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD	Effect of Nitric Oxide (NO) Supplementation on Neurocognitive Measures in Argininosuccinate Lyase Deficiency (ASLD)	Argininosuccinate Lyase Deficiency;Urea Cycle Disorder;Urea Cycle Disorders, Inborn;Argininosuccinic Aciduria	Dietary Supplement: Neo-ASA;Dietary Supplement: Placebo	Baylor College of Medicine	Rare Diseases Clinical Research Network;Neogenis Laboratories	Completed	6 Years	50 Years	All	16	N/A	United States
2	NCT02252770 (ClinicalTrials.gov)	September 2014	25/9/2014	Nitric Oxide Supplementation in Argininosuccinic Aciduria	Nitric Oxide Supplementation as a Therapeutic Intervention in Argininosuccinic Aciduria	Argininosuccinic Aciduria;Argininosuccinate Lyase Deficiency;Urea Cycle Disorders	Dietary Supplement: Nitric oxide supplement;Dietary Supplement: Placebo	Baylor College of Medicine	NULL	Completed	8 Years	64 Years	All	12	N/A	United States